Vanguard Investments Australia
WVE icon

Vanguard Investments Australia’s Wave Life Sciences WVE Stock Holding History

Vanguard Investments Australia’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161K Hold
27,701
– – ﹤0.01% 2198
2026
Q1 		$201K Buy
+27,701
New +$361K ﹤0.01% 2031

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Vanguard Investments Australia's WVE Position: Q2 2026 in Review

Vanguard Investments Australia held its Wave Life Sciences (WVE) position steady in Q2 2026 at 27,701 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

Vanguard Investments Australia first reported a position in WVE in Q1 2026 and has held it in 2 quarters since. The position peaked at $201K in Q1 2026. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Vanguard Investments Australia held 27,701 shares of Wave Life Sciences worth $161K as of Q2 2026.
  • Vanguard Investments Australia left its Wave Life Sciences share count unchanged in Q2 2026.
  • Wave Life Sciences made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #2198 holding.
  • Vanguard Investments Australia first reported a position in Wave Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Investments Australia's Wave Life Sciences position peaked at $201K in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.